TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Frequently asked questions
What sector does Tela Bio Inc (TELA) operate in?
Tela Bio Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Tela Bio Inc (TELA) current stock price?
As of the latest data, Tela Bio Inc stock price is $0.98, with a previous close of $0.97. Tela Bio Inc gained $0.02 in the last trading session, representing a 1.76% increase.
What is Tela Bio Inc (TELA) current market capitalization?
Tela Bio Inc market cap is approximately 44.33 million.
What is Tela Bio Inc (TELA) Earnings Per Share (EPS)?
The trailing EPS is -$0.77, and the forward EPS is -$0.45.
What is Tela Bio Inc (TELA) EBITDA?
Tela Bio Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.86 million.
Does Tela Bio Inc (TELA) pay dividends?
No. Tela Bio Inc does not pay a dividend.
How did Tela Bio Inc (TELA) perform in its most recent earnings report?
In the last report (June 30, 2026), Tela Bio Inc posted an EPS surprise of -17.65% and a revenue surprise of -3.59%.
When is Tela Bio Inc (TELA) next earnings report?
Tela Bio Inc is expected to release its next earnings report on September 30, 2026.
What is Tela Bio Inc (TELA) beta (volatility) score?
Tela Bio Inc has a beta of 1.360, suggesting it is more volatile than the market.
